Slides on Key Decisions in HIV Care: Treatment Considerations for Transgender PWH

Learn some of the key considerations for ART management for transgender PWH including providing care within a gender-affirmative care model, considering drug-drug interactions between hormone therapy and ART, and addressing barriers to engagement and retention in care.
Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS
Format: Microsoft PowerPoint (.ppt)
File Size: 206 KB
Released: April 29, 2022

Acknowledgements

Educational grant provided by:
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings